11 Apr, 2026
Feel free to reach out to us.
11 Apr, 2026
The prostate is a small, firm gland roughly the size of a walnut, positioned just below the bladder in men. Its job is to produce the fluid that carries and nourishes sperm. Prostate cancer occurs when cells within this gland accumulate genetic damage and begin dividing without restraint, eventually forming a tumor. Most cases grow slowly over many years.
Prostate cancer starts when certain harmful mutations permanently damage the DNA structure within the prostate cells. The affected cell stops responding to biological stop signals, divides continuously, and slowly builds a mass of abnormal tissue inside the gland.
This process can unfold over a decade with no pain, no urinary trouble, and nothing at all to feel. That prolonged silence is precisely why the PSA blood test matters so much clinically. It can detect molecular disruption long before the body produces any warning sign that a man would notice on his own.
| Feature | Normal Prostate | Cancerous Prostate |
|---|---|---|
| Cell behavior | Cells grow and function normally with controlled division | Cells accumulate genetic damage and divide without restraint |
| Tissue growth | No abnormal mass formation | An abnormal tissue mass (tumor) forms in the gland |
| Symptoms | Typically no urinary problems | May cause a weak urinary stream, burning urination, frequent urination, blood in urine or semen |
| Spread | Not applicable | Advanced cases can spread to bones and lymph nodes |
Age is the most reliably documented risk factor for prostate cancer. The risk climbs noticeably after 50 and accelerates past 65. A man with a father or brother previously diagnosed faces approximately double the average population risk. If that relative also had a BRCA2 gene mutation, the risk of getting cancer is even greater, and the cancer may be more aggressive than usual.
Lifestyle factors carry independent weight. Diets consistently high in red meat and full-fat dairy products appear alongside elevated prostate cancer risk in observational research. Excess body weight adds further pressure, particularly for men already carrying familial risk markers. None of these factors operate as a guarantee. They are probability shifters, not certainties, and that distinction matters when a man is deciding whether to pursue proactive screening.
Early prostate cancer is usually silent. Symptoms, when they do eventually surface, tend to reflect one of two things: a tumor large enough to compress the urethra or a disease that has extended outside the gland itself.
Common signs include:
Here's where clinical judgment becomes essential. These same symptoms are produced by benign prostatic hyperplasia, a non-cancerous gland enlargement extremely common in men over 50, and by prostatitis, which is inflammatory in nature.
No symptom on this list confirms cancer. What each symptom does confirm is the need for proper medical evaluation, not watchful waiting at home.
| Aspect | Early Prostate Cancer | Advanced Prostate Cancer |
|---|---|---|
| Symptoms | Usually no symptoms | Symptoms may appear |
| Detection | Often detected through a PSA test before symptoms | Identified after the spread of noticeable symptoms |
| Spread | Localized within the prostate gland | May spread to bones and lymph nodes |
| Prognosis | Favorable when found before it spreads | More serious once it spreads outside the gland |
At HCG, every diagnostic workup follows a structured sequence rather than relying on any single test:
Our multidisciplinary tumor boards at HCG bring together urologic oncologists, radiologists, and pathologists to review every case before a treatment pathway is recommended. No patient receives a plan based on one clinician's assessment alone.
HCG's Early Cancer Alert Checkup Package for Men includes a PSA test, CBC, abdominal ultrasound, and chest X-ray, starting at approximately ₹1,799. For most Indian men, this represents an accessible entry point for structured prostate cancer risk assessment.
When treatment becomes necessary, costs scale with disease stage and the modality selected. Surgery, radiation therapy, and hormonal therapy each carry different financial structures. Broadly, prostate cancer treatment in India ranges from Rs. 2.5 lakh to Rs. 15 lakh or more, with hospitals in cities like Bangalore, Mumbai, and Chennai typically sitting at the higher end compared to Tier-2 centers.
Note: The costs vary by hospital and patient profile, and the above shared costs are approximate estimates only.
Most prostate cancers grow slowly enough to allow careful, informed decision-making. The window that slow biology creates is most valuable when it is used proactively rather than waiting for symptoms that may never come in early disease. Knowing your risk, acting on it with a PSA test, and following through on any abnormal findings are three steps that consistently tilt the odds in a patient's favor.
Disclaimer:This information is intended to educate patients and caregivers. It does not replace professional medical advice. All treatment decisions should be made in consultation with a qualified doctor.
